Topic: Precision Medicine
We all know them—and we've probably used them. Now, weigh in on the buzziest words in healthcare that have nearly lost all meaning from overuse.
Up to 250,000 veterans could receive access to no-cost pharmacogenomic testing by 2022 under a new partnership with Sanford Health.
St. Jude Children's Research Hospital CEO James Downing is trying to expand the reach of the research campus to kids worldwide.
The number of FDA-approved therapies for personalized medicines has jumped from 20% to 40% in the last few years.
Press Ganey has elevated CEO Patrick Ryan to executive chairman, plus more healthcare headlines.
Over the five years of their partnership, GE and Vanderbilt will work to deliver safer and more precise immunotherapy treatment for cancer patients.
A panel recommended studying the feasibility of a unified EHR for California—something both patients and providers would be able to access.
Billionaire philanthropist Sean Parker explains why he's so bullish on cell therapy as part of his Parker Institute for Cancer Immunotherapy.
A new guide released by the Northeast Business Group on Health offered some guidelines for employers about how to figure out what's worth covering.
NIH Director Francis Collins says there's still plenty to be done to bring precision medicine to its full potential.